Methaqualone
Methaqualone is a sedative and hypnotic medication. It was sold under the brand names Quaalude and Sopor among others, and sold as a combination drug under the brand name Mandrax which contained 250mg methaqualone and 25mg diphenhydramine within the same tablet. Commercial production of methaqualone was halted due to widespread abuse, among other things. It is a member of the quinazolinone class. The sedativeâ€“hypnotic activity of methaqualone was first noted in 1955. In 1962, methaqualone was patented in the United States by Wallace and Tiernan. Its use peaked in the early 1970s for the treatment of insomnia, and as a sedative and muscle relaxant. Methaqualone became increasingly popular as a recreational drug and club drug in the late 1960s and 1970s, known variously as "ludes" or "sopers" (also "soaps") in the United States and "mandrakes" and "mandies" in the United Kingdom, Australia and New Zealand. The substance was sold both as a free base and as salt (hydrochloride). It is also a common date rape drug. Medical use Methaqualone is a sedative that increases the activity of the GABA receptors in the brain and nervous system, similarly to benzodiazepines and barbiturates. When GABA activity is increased, blood pressure drops and 